# Gent for Pharyngeal Gonorrhea (GC)

> **NCT03632109** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Washington** · enrollment: 13 (actual)

## Conditions studied

- Pharyngeal Gonococcal Infection

## Interventions

- **DRUG:** gentamicin 360mg IM

## Key facts

- **NCT ID:** NCT03632109
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-17
- **Primary completion:** 2019-03-12
- **Final completion:** 2019-03-12
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Efficacy
- **Last updated:** 2020-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03632109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03632109, "Gent for Pharyngeal Gonorrhea (GC)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03632109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*